A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy

NCT01252056 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

353

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Nephropathy

Interventions

DRUG: Probucol
DRUG: Probucol and Cilostazol

Sponsor

Otsuka Beijing Research Institute